Neuroscience Antibodies & Assays Market : Rising Incidence of Neurological Diseases
The global neuroscience antibodies and assays market is expected to reach USD 4.18 billion by 2023 from USD 2.57 billion in 2018, at a CAGR of 10.2%. Growth in this market is driven by the rising incidence of neurological diseases, increasing investments in neuroscience research, and growth in the pharmaceutical and biotechnology industries. On the other hand, quality and cost concerns over the production...
Immunoassay Market | Increasing Adoption of Immunoassay-Based Point-Of-Care Testing and Rapid Testing
The immunoassays market is expected to reach USD 27.15 billion by 2023 from USD 20.19 billion in 2018, at a CAGR of 6.1%. Factors driving the growth of this market include the increasing adoption of immunoassay-based point-of-care (POC) testing and rising incidence of chronic diseases across the world.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=436
The global immunoassays...
Biomarker Technologies Market : Increasing Utility of Biomarkers for Diagnostic Purposes And Rising Biomarker Research
The global biomarker technologies market was valued at USD 46.97 billion in 2017. It is expected to reach USD 74.51 billion in 2022, at CAGR of 9.7% during the forecast period.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=190358765
The growth of this market is mainly driven by increasing healthcare expenditure, rising R&D funding, the increasing utility of biomarkers...
Opportunities of Medical Device Connectivity Market in Healthcare Industry
The global medical device connectivity market is projected to reach USD 2,670.3 million by 2023 from USD 939.4 million in 2018, at a CAGR of 23.2%. Growth in this market can be attributed to a number of factors such as the increasing penetration of EHRs & health information exchange systems in healthcare organizations, healthcare IT initiatives driving the integration of medical devices with hospital...
Growing Adoption of Open Innovation Models Dominating High Throughput Screening Market
The global high-throughput screening (HTS) market is projected to reach USD 21.69 billion by 2023 from USD 14.87 billion in 2018, at a CAGR of 7.8%. Factors such initiatives undertaken by pharmaceutical and biotechnology companies, increasing R&D spending, technological advancements in HTS, and the availability of government funding and venture capital investments are driving the growth of the...
Reducing Cost of Sequencing and Growing Volume of Data Generated During Sequencing Driving Bioinformatics Services Market
The global bioinformatics services market is projected to reach USD 3.53 billion by 2023 from USD 1.70 billion in 2018, at a CAGR of 15.7%. Factors such as growing applications of bioinformatics in various industries, increasing public-private sector funding for bioinformatics services, and the shortage of skilled bioinformatics professionals leading to increased outsourcing of bioinformatics projects...
Growing Prevalence of Animal Diseases Causing Pain and Inflammation Driving Veterinary Pain Management Market
The veterinary pain management market is projected to reach USD 1.66 billion by 2023 from USD 1.13 billion in 2018, at a CAGR of 8.0% during the forecast period. Factors such as growth in companion animal adoption, increasing number of veterinary practitioners and their rising income levels in developed economies, growing prevalence of animal disease causing pain and inflammation, and rising adoption...
Sleep Apnea Devices Market by Type & End User – 2023
The sleep apnea devices market is projected to reach USD 6.49 billion by 2023 from an estimated USD 4.44 billion in 2018, at a CAGR of 7.8%. Growing awareness regarding the ill effects of sleep apnea, growing usage of oral appliances for sleep apnea treatment, and the large pool of undiagnosed and untreated sleep apnea patients are the major factors driving the growth of the market. Technological advancements...
Increasing Prevalence of Infectious Diseases Drives The Growth of The Global Infectious Disease Diagnostics Market
The global infectious disease diagnostics market is projected to reach USD 19.35 billion in 2022 from USD 14.73 billion in 2017, at CAGR of 5.6%. Growth in this market will largely be driven by the increasing global prevalence of infectious diseases, shift in focus from centralized laboratories to decentralized point-of-care testing, and growth in funding for research on infectious disease diagnostics
Download...
Launch of Advanced Cell Culture Products Driving Cell Culture Market
The global cell culture market is expected to reach USD 26.28 billion by 2023 from USD 15.32 billion in 2018, at a CAGR of 11.4%. Growth in this market is driven by the growing number of regulatory approvals for cell culture-based vaccines, increasing demand for monoclonal antibodies (mAbs), funding for cell-based research, growing preference for single-use technologies, and the launch of advanced...